Do not use fasting plasma glucose, random blood glucose, HbA1c, glucose challenge test or urinalysis for glucose to assess risk of developing gestational diabetes. Do not do February 2015 Unclassified
Do not use HbA1c levels routinely to assess a woman's blood glucose control in the second and third trimesters of pregnancy. Do not do February 2015 Unclassified
Do not offer continuous glucose monitoring routinely to pregnant women with diabetes. Do not do February 2015 Unclassified
Diabetic retinopathy should not be considered a contraindication to vaginal birth. Do not do February 2015 Unclassified
Routine monitoring of fetal wellbeing (using methods such as fetal umbilical artery Doppler recording, fetal heart rate recording and biophysical profile testing) before 38 weeks is not recommended in pregnant women with diabetes, unless there is a risk of fetal growth restriction. Do not do February 2015 Unclassified
Diabetes should not be considered a contraindication to antenatal steroids for fetal lung maturation or to tocolysis. Do not do February 2015 Unclassified
Do not use betamimetic medicines for tocolysis in women with diabetes. Do not do February 2015 Unclassified
Do not transfer babies of women with diabetes to community care until they areat least 24 hours old, and not before you are satisfied that the baby is maintaining blood glucose levels and is feeding well. Do not do February 2015 Unclassified
For women who were diagnosed with gestational diabetes and whose bloodglucose levels returned to normal after the birth, do not routinely offer a 75 g 2-hour OGTT. Do not do February 2015 Unclassified